<HTML>
<HEAD>
<BASE target="_top">
<TITLE>United States Patent: 7029663</TITLE></HEAD>
<!-BUF1=7029663
BUF7=2006
BUF8=17199
BUF9=/1/
BUF51=7
-->
<BODY bgcolor="#FFFFFF">
<A name="top"></A>
<CENTER>
<IMG src="/netaicon/PTO/patfthdr.gif" alt="[US Patent & Trademark Office, Patent Full Text and Image Database]">
<BR>
<TABLE>
<TR><TD align="center">
<A href="/netahtml/PTO/index.html"><IMG src="/netaicon/PTO/home.gif" alt="[Home]" border="0" valign="middle"></A>
<A href="/netahtml/PTO/search-bool.html"><IMG src="/netaicon/PTO/boolean.gif" alt="[Boolean Search]" border="0" valign="middle"></A>
<A href="/netahtml/PTO/search-adv.htm"><IMG border="0" src="/netaicon/PTO/manual.gif" ALT="[Manual Search]" valign="middle"></A>
<A href="/netahtml/PTO/srchnum.htm"><IMG src="/netaicon/PTO/number.gif" alt="[Number Search]" border="0" valign="middle"></A>
<A href="/netahtml/PTO/help/help.htm"><IMG border="0" valign="middle" src="/netaicon/PTO/help.gif" ALT="[Help]"></A>
</TD></TR>
<TR><TD align="center">
   <A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=99&p=1&f=S&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&Query=+((ttl/aspirin+or+abst/aspirin))><IMG VALIGN=MIDDLE SRC=/netaicon/PTO/prevlist.gif border=0 ALT=[PREV_LIST]></A>
<A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=99&p=2&f=S&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&Query=+((ttl/aspirin+or+abst/aspirin))><IMG VALIGN=MIDDLE SRC=/netaicon/PTO/hitlist.gif border=0 ALT=[HIT_LIST]></A>
<A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=99&p=3&f=S&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&Query=+((ttl/aspirin+or+abst/aspirin))><IMG VALIGN=MIDDLE SRC=/netaicon/PTO/nextlist.gif border=0 ALT=[NEXT_LIST]></A>
<A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=98&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))><IMG VALIGN=MIDDLE SRC=/netaicon/PTO/prevdoc.gif border=0 ALT=[PREV_DOC]></A>
<A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=100&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))><IMG VALIGN=MIDDLE SRC=/netaicon/PTO/nextdoc.gif border=0 ALT=[NEXT_DOC]></A>

<A href="#bottom"><IMG src="/netaicon/PTO/bottom.gif" alt="[Bottom]" valign="middle" border="0"></A>
</TD></TR>
   <TR><TD align="center">
   <A href="https://certifiedcopycenter.uspto.gov/other/patft/view.html?backUrl1=http%3A//patft.uspto.gov/netacgi/nph-Parser?Sect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%25252Fnetahtml%25252FPTO%25252Fsearch-adv.htm%26r%3D99%26p%3D2%26f%3DG%26l%3D50%26d%3DPTXT%26S1%3D(aspirin.TI.%252BOR%252Baspirin.ABTX.)%26OS%3D%252B((ttl%2Faspirin%252Bor%252Babst%2Faspirin))&backLabel1=Back%20to%20Document%3A%207029663"><IMG border="0" src="/netaicon/PTO/cart.gif" border="0" valign="middle" alt="[View Shopp
ing Cart]"></A>
   <A href="https://certifiedcopycenter.uspto.gov/other/patft/order.html?docNumber=7029663&backUrl1=http%3A//patft.uspto.gov/netacgi/nph-Parser?Sect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%25252Fnetahtml%25252FPTO%25252Fsearch-adv.htm%26r%3D99%26p%3D2%26f%3DG%26l%3D50%26d%3DPTXT%26S1%3D(aspirin.TI.%252BOR%252Baspirin.ABTX.)%26OS%3D%252B((ttl%2Faspirin%252Bor%252Babst%2Faspirin))&backLabel1=Back%20to%20Document%3A%207029663">
   <IMG border="0" src="/netaicon/PTO/order.gif" valign="middle" alt="[Add to Shopping Cart]"></A>
   </TD></TR>
   <TR><TD align="center">
   <a href=http://pdfpiw.uspto.gov/.piw?Docid=07029663&homeurl=http%3A%2F%2Fpatft.uspto.gov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%2526Sect2%3DHITOFF%2526u%3D%25252Fnetahtml%25252FPTO%25252Fsearch-adv.htm%2526r%3D99%2526p%3D2%2526f%3DG%2526l%3D50%2526d%3DPTXT%2526S1%3D(aspirin.TI.%252BOR%252Baspirin.ABTX.)%2526OS%3D%252B((ttl%2Faspirin%252Bor%252Babst%2Faspirin))%2526RS%3D(TTL%2Faspirin%252BOR%252BABST%2Faspirin)&PageNum=&Rtype=&SectionNum=&idkey=NONE&Input=View+first+page><img src="/netaicon/PTO/image.gif" alt="[Image]" border="0" valign="middle"></A>

   </TD></TR>
</TABLE>
</CENTER>
<TABLE width="100%">
<TR><TD align="left" width="50%">&nbsp;</TD>
<TD align="right" valign="bottom" width="50%"><FONT size="-1">( <STRONG>99</STRONG></FONT> <FONT size=-2>of</FONT> <STRONG><FONT size=-1>291</STRONG> )</FONT></TD></TR></TABLE>
<HR>
   <TABLE width="100%">
   <TR>	<TD align="left" width="50%"><b>United States Patent </b></TD>
   <TD align="right" width="50%"><b>7,029,663</b></TD>
   </TR>
     <TR><TD align="left" width="50%"><b>
         Mizobuchi
, &nbsp; et al.</b>
     </TD>
     <TD align="right" width="50%"> <b>
     April 18, 2006
</b></TD>
     </TR>
     </TABLE>
       <HR>
       <FONT size="+1">Stable ointment containing acetylsalicylic acid
</FONT><BR>
       <BR><CENTER><b>Abstract</b></CENTER>
       <p> A substantially anhydrous stable ointment containing <B><I>Aspirin</I></B> which is
     characterized in using gelation hydrocarbon and/or vaseline as a base.
     The ointment is superior in stability and can be stored for a long term.
</p>
       <HR>
<TABLE width="100%"> <TR> <TH scope="row" valign="top" align="left" width="10%">Inventors:</TH> <TD align="left" width="90%">
 <B>Mizobuchi; Noriko</B> (Kochi, <B>JP</B>)<B>, Hasegawa; Yuichi</B> (Kakogawa, <B>JP</B>)<B>, Kawada; Mitsuhiro</B> (Kagawa-ken, <B>JP</B>)<B>, Hisaichi; Shin-ichi</B> (Kagawa-ken, <B>JP</B>) </TD> </TR>
<TR> <TH scope="row" valign="top" align="left" width="10%">Assignee:</TH>
<TD align="left" width="90%">

<B>Teikoku Seiyaku Co., Ltd.</B>
 (Ohkawa-gun, 
<B>JP</B>)
<BR>

</TD>
</TR>
       <TR><TH scope="row" valign="top" align="left" width="10%" nowrap>Family ID:
       </TD><TD align="left" width="90%">
       <b>15869442
</b></TD></TR>
       <TR><TH scope="row" valign="top" align="left" width="10%" nowrap>Appl. No.:
       </TH><TD align="left" width="90%">
       <b>09/242,700</b></TD></TR>
       <TR><TH scope="row" valign="top" align="left" width="10%">Filed:
       </TH><TD align="left" width="90%">
       <b>June 23, 1998</b></TD></TR>
       <TR><TH scope="row" valign="top" align="left" width="10%">PCT Filed:
       </TH><TD align="left" width="90%"><b>
       June 23, 1998
       </b></TD></TR>
       <TR><TH scope="row" valign="top" align="left" width="10%">PCT No.:
       </TH><TD align="left" width="90%"><b>
       PCT/JP98/02781
       </b></TD></TR>
         <TR><TH scope="row" valign="top" align="left" width="15%">371(c)(1),(2),(4) Date:
         </TH><TD align="left" width="85%"><b>
         April 19, 1999
         </b></TD></TR>
       <TR><TH scope="row" valign="top" align="left" width="10%" nowrap>PCT Pub. No.:
       </TH><TD align="left" width="90%">
       <b>
       WO98/58652
       </b></TD></TR>
       <TR><TH scope="row" valign="top" align="left" width="10%" nowrap>PCT Pub. Date:
       </TH><TD align="left" width="90%">
       <b>
       December 30, 1998
       </b></TD></TR>
     </TABLE>
     <HR>
<CENTER><b>Foreign Application Priority Data</b></CENTER> <hr align="center" width="30%"> <TABLE width="100%"> <TR><TH scope="col"></TH><TD></TD><TD></TD><TH scope="col"></TH><TD></TD></TR> <TR><TD align="center">
Jun 25, 1997
[JP]</TD><TD></TD><TD></TD><TD align='left'>
9-168513</TD></TR><TR><TD align=center>

</TD>
</TR> </TABLE>
<p> <TABLE width="100%"> <TR><TD valign="top" align="left" width="30%"><b>Current U.S. Class:</b></TD> <TD valign="top" align="right" width="70%"><b>424/78.05</b>; 514/165; 424/78.02; 514/887; 514/947; 514/944; 424/400 </TD></TR> 
       <TR><TD valign="top" align="left" width="30%"><b>Current CPC Class: </b></TD>
       <TD valign="top" align="right" width="70%">A61K 47/06&nbsp(20130101); A61P 29/00&nbsp(20180101); A61K 9/0014&nbsp(20130101); A61K 9/06&nbsp(20130101); A61K 31/616&nbsp(20130101); A61K 31/60&nbsp(20130101); A61P 25/04&nbsp(20180101); Y10S 514/944&nbsp(20130101); Y10S 514/887&nbsp(20130101); Y10S 514/947&nbsp(20130101)</TD></TR>
         <TR><TD valign="top" align="left" width="30%"><b>Current International Class: </b></TD>
         <TD valign="top" align="right" width="70%">A61K 31/74&nbsp(20060101); A61K 9/00&nbsp(20060101); A01N 37/36&nbsp(20060101)</TD></TR>
       <TR><TD valign="top" align="left" width="30%"><b>Field of Search: </b></TD>
       <TD align="right" valign="top" width="70%">
       









 ;514/944,938,887,947,165 ;424/78.05,400,401,78.02,78.07
       </TD></TR>
     </TABLE>
<HR><CENTER><b>References Cited  <A href="/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2Fsearch-adv.htm&r=0&f=S&l=50&d=PALL&Query=ref/7029663">[Referenced By]</A></b></CENTER>       <HR>
       <CENTER><b>U.S. Patent Documents</b></CENTER>
<TABLE width="100%"> <TR><TH scope="col" width="33%"></TH> <TH scope="col" width="33%"></TH> <TH scope="col" width="34%"></TH></TR> <TR> <TD align="left">
<a href="/netacgi/nph-Parser?Sect2=PTO1&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&d=PALL&RefSrch=yes&Query=PN%2F4012508">4012508</a></TD><TD align =left>
March 1977</TD><TD align=left>
Burton</TD></TR><TR><TD align=left>
<a href="/netacgi/nph-Parser?Sect2=PTO1&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&d=PALL&RefSrch=yes&Query=PN%2F4164563">4164563</a></TD><TD align =left>
August 1979</TD><TD align=left>
Chang</TD></TR><TR><TD align=left>
<a href="/netacgi/nph-Parser?Sect2=PTO1&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&d=PALL&RefSrch=yes&Query=PN%2F4228162">4228162</a></TD><TD align =left>
October 1980</TD><TD align=left>
Luzzi et al.</TD></TR><TR><TD align=left>
<a href="/netacgi/nph-Parser?Sect2=PTO1&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&d=PALL&RefSrch=yes&Query=PN%2F4613498">4613498</a></TD><TD align =left>
September 1986</TD><TD align=left>
Crosby</TD></TR><TR><TD align=left>
<a href="/netacgi/nph-Parser?Sect2=PTO1&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&d=PALL&RefSrch=yes&Query=PN%2F4665063">4665063</a></TD><TD align =left>
May 1987</TD><TD align=left>
Bar-Shalom</TD></TR><TR><TD align=left>
<a href="/netacgi/nph-Parser?Sect2=PTO1&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&d=PALL&RefSrch=yes&Query=PN%2F4686212">4686212</a></TD><TD align =left>
August 1987</TD><TD align=left>
Ducatman et al.</TD></TR><TR><TD align=left>
<a href="/netacgi/nph-Parser?Sect2=PTO1&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&d=PALL&RefSrch=yes&Query=PN%2F4794107">4794107</a></TD><TD align =left>
December 1988</TD><TD align=left>
Takashima et al.</TD></TR><TR><TD align=left>
<a href="/netacgi/nph-Parser?Sect2=PTO1&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&d=PALL&RefSrch=yes&Query=PN%2F5916918">5916918</a></TD><TD align =left>
June 1999</TD><TD align=left>
Konishi et al.</TD></TR><TR><TD align=left>

</TD>
</TR> </TABLE>
       <CENTER><b>Foreign Patent Documents</b></CENTER>
<TABLE width="100%"> <TR><TD></TD><TH scope="col"></TH> <TD></TD><TH scope="col"></TH> <TD></TD><TH scope="col"></TH></TR> <TR> <TD align="left">
</TD><TD align=left>469526</TD><TD></TD><TD align=left>
Jul 1937</TD><TD></TD><TD align=left>
GB</TD></TR><TR><TD align=left>
</TD><TD align=left>2144326</TD><TD></TD><TD align=left>
Mar 1985</TD><TD></TD><TD align=left>
GB</TD></TR><TR><TD align=left>
</TD><TD align=left>2144326</TD><TD></TD><TD align=left>
Mar 1985</TD><TD></TD><TD align=left>
GB</TD></TR><TR><TD align=left>
</TD><TD align=left>2144326</TD><TD></TD><TD align=left>
Mar 1996</TD><TD></TD><TD align=left>
GB</TD></TR><TR><TD align=left>
</TD><TD align=left>5632425</TD><TD></TD><TD align=left>
Apr 1981</TD><TD></TD><TD align=left>
JP</TD></TR><TR><TD align=left>
</TD><TD align=left>6289619</TD><TD></TD><TD align=left>
Apr 1987</TD><TD></TD><TD align=left>
JP</TD></TR><TR><TD align=left>
</TD><TD align=left>62267232</TD><TD></TD><TD align=left>
Nov 1987</TD><TD></TD><TD align=left>
JP</TD></TR><TR><TD align=left>
</TD><TD align=left>372426</TD><TD></TD><TD align=left>
Mar 1991</TD><TD></TD><TD align=left>
JP</TD></TR><TR><TD align=left>
</TD><TD align=left>03072426</TD><TD></TD><TD align=left>
Mar 1991</TD><TD></TD><TD align=left>
JP</TD></TR><TR><TD align=left>
</TD><TD align=left>4346930</TD><TD></TD><TD align=left>
Dec 1992</TD><TD></TD><TD align=left>
JP</TD></TR><TR><TD align=left>
</TD><TD align=left>5246892</TD><TD></TD><TD align=left>
Sep 1993</TD><TD></TD><TD align=left>
JP</TD></TR><TR><TD align=left>
</TD><TD align=left>672879</TD><TD></TD><TD align=left>
Mar 1994</TD><TD></TD><TD align=left>
JP</TD></TR><TR><TD align=left>
</TD><TD align=left>6183980</TD><TD></TD><TD align=left>
Jul 1994</TD><TD></TD><TD align=left>
JP</TD></TR><TR><TD align=left>
</TD><TD align=left>8113531</TD><TD></TD><TD align=left>
May 1996</TD><TD></TD><TD align=left>
JP</TD></TR><TR><TD align=left>
</TD><TD align=left>8208487</TD><TD></TD><TD align=left>
Aug 1996</TD><TD></TD><TD align=left>
JP</TD></TR><TR><TD align=left>
</TD><TD align=left>9235232</TD><TD></TD><TD align=left>
Sep 1997</TD><TD></TD><TD align=left>
JP</TD></TR><TR><TD align=left>

</TD>
</TR> </TABLE>
<TABLE width="90%"> <BR> <CENTER><b>Other References</b></CENTER> <TR><TD><align="left"><BR>Journal of the Nippon Hospital Pharmacists Association, vol. 20, No. 6 (1994), p. 502-508. cited by other
.<BR>Pharmaceutics, Published by the Press of Human Hygiene, 3.sup.rd Ed., Edited by Xi, Nian Zhu, pp. 376-377, (1995) with an English translation thereof. cited by other. </TD></TR> </TABLE> <BR>
       <i>Primary Examiner:</i> Padmanabhan; Sreeni
<BR>
       <i>Assistant Examiner:</i> Gollamudi; Sharmila S.
<BR>
       <i>Attorney, Agent or Firm:</i> <coma>Birch, Stewart, Kolasch & Birch, LLP
<BR>
         <HR>
<CENTER><b><i>Claims</b></i></CENTER> <HR> <BR><BR>The invention claimed is: <BR><BR> 1.  An ointment consisting of acetyl salicylic acid and a base selected from the group consisting of hydrocarbon gel, petrolatum and a mixture thereof without any other
additive for said acetyl salicylic acid and wherein the ointment does not contain water for dissolving said acetyl salicylic acid, wherein when the base is hydrocarbon gel or a mixture of hydrocarbon gel and petrolatum, the acetyl salicylic acid is in a
range of 20 to 30% by weight per total weight, and wherein when the base is petrolatum, the acetyl salicylic acid is in a range of 25 to 30% by weight per total weight.
<BR><BR> 2.  The ointment of claim 1, wherein the ointment is an anhydrous ointment.
<BR><BR> 3.  The ointment of claim 1, wherein the base is petrolatum.
<BR><BR> 4.  The ointment of claim 3, wherein the petrolatum is selected from the group consisting of white petrolatum and yellow petrolatum.
<BR><BR> 5.  The ointment of claim 1, wherein the base is hydrocarbon gel. <HR> <CENTER><b><i>Description</b></i></CENTER> <HR> <BR><BR> This application is the national phase under 35 U.S.C.  .sctn.371 of prior PCT International Application No.
PCT/JP98/02781 which has an International filing date of Jun.  23, 1998 which designated the United States of America.
<BR><BR>TECHNICAL FIELD
<BR><BR> The present invention relates to a stable ointment containing Aspirin (acetyl salicylic acid).
<BR><BR> More specifically, the present invention relates to a substantially anhydrous ointment containing Aspirin characterized in using hydrocarbon gel and/or vaseline (petrolatum) as a base, which can preserve Aspirin stably for a long term.
<BR><BR>BACKGROUND ART
<BR><BR> Aspirin has been used as anti-inflammatoric antipyretic analgesics from of old.  It is in general orally administered in form of tablets, granules and so on.
<BR><BR> However, due to the intestinal injury by Aspirin, its external application has been recently studied and it has been done to try to make it percutaneously absorb.  The results are reported in Japanese Patent Pub.  No. 3-72426 in form of
ointments for treatment of neuralgia, in Japanese Patent Pub.  No. 6-72879 in form of patches containing Aspirin, in Japanese Patent Pub.  No. 6-183980 as a stabilizing method of Aspirin in patches containing it.  Further, patches containing Aspirin are
disclosed in Japanese Patent Pub.  No. 8-113531.  Techniques such as improvement of transdermal absorption of Aspirin and stabilization of it in plasters are mainly disclosed in these publications.  However, any technique to maintain Aspirin stably in
ointments for a long term is not disclosed.
<BR><BR> The literatures which describe methods for stabilization of Aspirin in preparations except for external preparations, are Japanese Patent Pub.  No. 56-32425, Japanese Patent Pub.  No. 62-89619, Japanese Patent Pub.  No. 4-346930 and so on.
<BR><BR> Because Aspirin is readily hydrolyzed even in the presence of small amount of water and furthermore, by depending on a kind of additives the hydrolysis is accelerated, in these literatures in order to avoid to contact with the additive, it is
disclosed to use the protective layer consisting of sucrose, or to use binders in which water was excluded as much as possible degree and to add a hydrogenated oil as a lubricant.  However, it is hardly possible to apply such techniques to ointments.
<BR><BR> As such, in external preparations of Aspirin, the technique to secure the stability of Aspirin in preparing ointments has not been shown.
<BR><BR>DISCLOSURE OF INVENTION
<BR><BR> The present invention was made considering the above problems and the object of the present invention is to provide ointments containing Aspirin which are superior in stability and can be stored for a long term.
<BR><BR> That is, by preparing substantially water free-ointments prepared by adding Aspirin to a base comprising hydrocarbon gel and/or vaseline (petrolatum) it was found to solve the above problems and thus the present invention was completed.
<BR><BR> Hydrocarbon gel and vaseline in the present invention are used in substantially anhydrous state.  Vaseline is one ordinary used as a base for preparation of ointments, such as yellow vaseline, white vaseline and their mixture.
<BR><BR> The amount of Aspirin in an ointment of the present invention is 0.001 to 30% by weight, preferably 0.01 to 20% by weight, more preferably 0.05 to 15% by weight.  In case of more than 30% by weight of Aspirin, it is impossible to maintain the
property of ointments and in addition the protection effect by the base decreases to cause hydrolysis of Aspirin.  On the other hand, in case of less than 0.001% by weight of Aspirin it is hardly to exhibit the pharmacological activities of Aspirin. 
Either case is not preferable.
<BR><BR> The ointments of the present invention containing Aspirin are prepared by the same method as ordinary ointments.  That is, after melting a base by warming, thereto fine powders of Aspirin are added under stirring and mixed to prepare ointments.
<BR><BR> In case of preparation of these ointments, to add water in order to dissolve Aspirin and the like is not preferable and should be avoided.
<BR><BR> Furthermore, it is not preferable to add any additive which destroys stability of Aspirin, such as an organic acid, an alcohol, a polyhydric alcohol, a surfactant, etc. <BR><BR>BEST MODE FOR CARRYING OUT THE INVENTION
<BR><BR> The present invention is shown in more detail by the following examples.  But the present invention is not limited by the examples.
<BR><BR>EXAMPLE 1
<BR><BR> According to the following ingredients, white vaseline was put in a vacuum emulsifier (T.K.ROBO MIXER prepared by Tokusyukika Kogyo) to be melted under heating at 55.degree.  C. Thereto Aspirin was added and the mixture was stirred under vacuum
at 2,000 rpm for 15 minutes.  Then the mixture was cooled to 25.degree.  C. to give ointments containing Aspirin.
<BR><BR> TABLE-US-00001 Ingredients Contents Aspirin 0.5 g White vaseline 99.5 g
<BR><BR>EXAMPLE 2
<BR><BR> According to the following ingredients, yellow vaseline and Aspirin were put in a grinder and the mixture was stirred at 100 rpm to give ointments containing Aspirin.
<BR><BR> TABLE-US-00002 Ingredients Contents Aspirin 8.0 g Yellow vaseline 92.0 g
<BR><BR>EXAMPLE 3
<BR><BR> According to the following ingredients, hydrocarbon gel and Aspirin were put in a grinder and the mixture was stirred at 80 rpm to give ointments containing Aspirin.
<BR><BR> TABLE-US-00003 Ingredients Contents Aspirin 5.0 g Hydrocarbon gel 99.5 g (Japanese Pharmaceutical Excipients)
<BR><BR>EXAMPLE 4
<BR><BR> According to the following ingredients, hydrocarbon gel and Aspirin were put in a planetary mixer and the mixture was stirred under vacuum at 130 rpm for 20 minutes to give ointments containing Aspirin.
<BR><BR> TABLE-US-00004 Ingredients Contents Aspirin 25.0 g Hydrocarbon gel 75.0 g (Japanese Pharmaceutical Excipients)
<BR><BR>EXAMPLE 5
<BR><BR> According to the following ingredients and the method described in Example 4, there were obtained ointments containing Aspirin.
<BR><BR> TABLE-US-00005 Ingredients Contents Aspirin 0.5 g Hydrocarbon gel 99.5 g (Japanese Pharmaceutical Excipients)
<BR><BR>EXAMPLE 6
<BR><BR> According to the following ingredients and the method described in Example 4, there were obtained ointments containing Aspirin.
<BR><BR> TABLE-US-00006 Ingredients Contents Aspirin 1.0 g Hydrocarbon gel 79.0 g (Japanese Pharmaceutical Excipients) White vaseline 20.0 g
<BR><BR>COMPARATIVE EXAMPLE 1
<BR><BR> According to the following ingredients, polyacrylic acid was added to propylene glycol and the mixture was melted by warming on a water bath and stirred.  Then, Aspirin was dissolved in the mixture and thereto triethanolamine was added.  The
mixture was stirred to give gelation ointments.
<BR><BR> TABLE-US-00007 Ingredients Contents Aspirin 0.5 g Polyacrylic acid 0.5 g Propylene glycol 45.0 g Triethanolamine 0.67 g Purified water residual Total 100.0 g
<BR><BR>COMPARATIVE EXAMPLE 2
<BR><BR> According to the following ingredients, carboxymethyl cellulose sodium was dispersed in ethanol.  The mixture was added to a mixture of glycerin and propylene glycol under stirring.  Then, Aspirin was dispersed and dissolved in the mixture. 
Thereto purified water was added and the mixture was stirred thoroughly to give gelation ointments.
<BR><BR> TABLE-US-00008 Ingredients Contents Aspirin 0.5 g Carboxymethyl cellulose sodium 6.0 g Ethanol 8.0 g Glycerin 20.0 g Propylene glycol 20.0 g Purified water residual Total 100.0 g
<BR><BR>COMPARATIVE EXAMPLE 3
<BR><BR> According to the following ingredients, hydrophilic ointments described in the Pharmacopeia of Japan XIII was prepared and thereto Aspirin was mixed to prepare a ointment.
<BR><BR> TABLE-US-00009 Ingredient of hydrophilic ointment White vaseline 25.0 g Stearyl alcohol 20.0 g Propylene glycol 12.0 g Polyoxyethylene hyroganated castor oil 4.0 g Glycerol monostearate 1.0 g p-Hydoxybenzoic acid methyl ester 0.1 g
p-Hydoxybenzoic acid propyl ester 0.1 g Purified water residual Total 100.0 g
<BR><BR> TABLE-US-00010 Ingredients of ointment containing Aspirin Aspirin 0.5 g Hydrophilic ointment 99.5 g
<BR><BR> Experiment 1
<BR><BR> Ointments of the present invention prepared by Examples 1 and 5, and ointments prepared by Comparative Examples 1 to 4 were tested on stability in strage at 75% RH at 40.degree.  C., and at 50.degree.  C. Test samples were stored under each
condition for one or two months, and after sampling, contents of Aspirin remaining in each sample were measured and the remaining percentage per initial contents was calculated and shown in Table 1.
<BR><BR> Experiment 2
<BR><BR> Ointments of the present invention prepared by examples 1 to 5 and ointments prepared by Comparative Example 1 were measured on the water contents in the by Karl-Fischer moisture content meter and the results were shown in Table 2.
<BR><BR> TABLE-US-00011 TABLE 1 Test result on the stability of ointments containing Aspirin 75% RH at 40.degree.  C. at 50.degree.  C. remain (%) remain (%) Initial 1 2 10.5 Initial 1 2 10.5 Example 1 100 100.6 1002.4 96.9 100 96.0 97.8 91.7 Example 5
100 101.2 1002.4 96.4 100 100.0 99.4 93.2 Comp.  Ex.  1 1001 15.4 1.2 0 100 0.8 0 Comp.  Ex.  2 100 13.8 1.4 0 100 0 0 Comp.  Ex.  3 100 20.7 0.4 0 100 0 0
<BR><BR> TABLE-US-00012 TABLE 2 The result of measurement of water content in ointments containing Aspirin Ex.  1 Ex.  2 Ex.  3 Ex.  4 Ex.  5 water contents (%) 0.0190 0.0261 0.0098 0.0127 0.0066 Com. Ex.  Com. Ex.  Com. Ex.  1 2 3 water contents %
55.2438 45.2190 38.0261
<BR><BR>INDUSTRIAL APPLICABILITY
<BR><BR> The ointments of the present invention containing Aspirin can be stored stably Aspirin for a long term in form of the substantially anhydrous ointment containing hydrocarbon gel and/or vaseline as a base.
<BR><BR><CENTER><b>* * * * *</b></CENTER>
<HR>
   <CENTER>
   <a href=http://pdfpiw.uspto.gov/.piw?Docid=07029663&homeurl=http%3A%2F%2Fpatft.uspto.gov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO2%2526Sect2%3DHITOFF%2526u%3D%25252Fnetahtml%25252FPTO%25252Fsearch-adv.htm%2526r%3D99%2526p%3D2%2526f%3DG%2526l%3D50%2526d%3DPTXT%2526S1%3D(aspirin.TI.%252BOR%252Baspirin.ABTX.)%2526OS%3D%252B((ttl%2Faspirin%252Bor%252Babst%2Faspirin))%2526RS%3D(TTL%2Faspirin%252BOR%252BABST%2Faspirin)&PageNum=&Rtype=&SectionNum=&idkey=NONE&Input=View+first+page><img src="/netaicon/PTO/image.gif" alt="[Image]" border="0" valign="middle"></A>
   <TABLE>
   <TR><TD align="center"><A href="https://certifiedcopycenter.uspto.gov/other/patft/view.html?backUrl1=http%3A//patft.uspto.gov/netacgi/nph-Parser?Sect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%25252Fnetahtml%25252FPTO%25252Fsearch-adv.htm%26r%3D99%26p%3D2%26f%3DG%26l%3D50%26d%3DPTXT%26S1%3D(aspirin.TI.%252BOR%252Baspirin.ABTX.)%26OS%3D%252B((ttl%2Faspirin%252Bor%252Babst%2Faspirin))&backLabel1=Back%20to%20Document%3A%207029663"><IMG border="0" src="/netaicon/PTO/cart.gif" border="0" valign="m
iddle" alt="[View Shopping Cart]"></A>
   <A href="https://certifiedcopycenter.uspto.gov/other/patft/order.html?docNumber=7029663&backUrl1=http%3A//patft.uspto.gov/netacgi/nph-Parser?Sect1%3DPTO2%26Sect2%3DHITOFF%26u%3D%25252Fnetahtml%25252FPTO%25252Fsearch-adv.htm%26r%3D99%26p%3D2%26f%3DG%26l%3D50%26d%3DPTXT%26S1%3D(aspirin.TI.%252BOR%252Baspirin.ABTX.)%26OS%3D%252B((ttl%2Faspirin%252Bor%252Babst%2Faspirin))&backLabel1=Back%20to%20Document%3A%207029663">
   <IMG border="0" src="/netaicon/PTO/order.gif" valign="middle" alt="[Add to Shopping Cart]"></A>
   </TD></TR>
   <TR><TD align="center">
     <A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=99&p=1&f=S&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&Query=+((ttl/aspirin+or+abst/aspirin))><IMG VALIGN=MIDDLE SRC=/netaicon/PTO/prevlist.gif border=0 ALT=[PREV_LIST]></A>
<A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=99&p=2&f=S&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&Query=+((ttl/aspirin+or+abst/aspirin))><IMG VALIGN=MIDDLE SRC=/netaicon/PTO/hitlist.gif border=0 ALT=[HIT_LIST]></A>
<A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=99&p=3&f=S&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&Query=+((ttl/aspirin+or+abst/aspirin))><IMG VALIGN=MIDDLE SRC=/netaicon/PTO/nextlist.gif border=0 ALT=[NEXT_LIST]></A>
<A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=98&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))><IMG VALIGN=MIDDLE SRC=/netaicon/PTO/prevdoc.gif border=0 ALT=[PREV_DOC]></A>
<A  HREF=/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=100&p=2&f=G&l=50&d=PTXT&S1=(aspirin.TI.+OR+aspirin.ABTX.)&OS=+((ttl/aspirin+or+abst/aspirin))><IMG VALIGN=MIDDLE SRC=/netaicon/PTO/nextdoc.gif border=0 ALT=[NEXT_DOC]></A>

   <A href="#top"><IMG valign="middle" src="/netaicon/PTO/top.gif" border="0" alt="[Top]"></A>
   </TD></TR>
   </TABLE>
   <A name="bottom"></A>
   <A href="/netahtml/PTO/index.html"><IMG src="/netaicon/PTO/home.gif" alt="[Home]" border="0" valign="middle"></A>
   <A href="/netahtml/PTO/search-bool.html"><IMG src="/netaicon/PTO/boolean.gif" alt="[Boolean Search]" border="0" valign="middle"></A>
   <A href="/netahtml/PTO/search-adv.htm"><IMG border="0" src="/netaicon/PTO/manual.gif" alt="[Manual Search]" valign="middle"></A>
   <A href="/netahtml/PTO/srchnum.htm"><IMG src="/netaicon/PTO/number.gif" alt="[Number Search]" border="0" valign="middle"></A>
   <A href="/netahtml/PTO/help/help.htm"><IMG border="0" src="/netaicon/PTO/help.gif" alt="[Help]" valign="middle"></A>
   </CENTER>
</BODY>
</HTML>